tarenflurbil has been researched along with carprofen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegretti, M; Berdini, V; Bertini, R; Bizzarri, C; Cesta, MC; Colotta, F; Di Bello, N; Di Bitondo, R; Di Cioccio, V; Fantucci, P; Florio, S; Galliera, E; Locati, M; Nano, G; Nicolini, L; Russo, V; Topai, A; Zampella, G | 1 |
Baumann, K; Dittrich, M; Greiner, C; Hieke, M; Ness, J; Schubert-Zsilavecz, M; Steri, R; Weggen, S; Werz, O; Zettl, H | 1 |
Berthelot, DJ; Gijsen, HJ; Oehlrich, D | 1 |
1 review(s) available for tarenflurbil and carprofen
Article | Year |
---|---|
γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.
Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cinnamates; Clinical Trials as Topic; Ginsenosides; Humans; Isoenzymes; Stereoisomerism | 2011 |
2 other study(ies) available for tarenflurbil and carprofen
Article | Year |
---|---|
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Chemotaxis, Leukocyte; Female; Humans; Ketoprofen; Ligands; Lymphoma; Macrophages, Peritoneal; Mice; Models, Molecular; Mutagenesis, Site-Directed; Propionates; Receptors, Interleukin-8A; Recombinant Proteins; Structure-Activity Relationship | 2005 |
Design, synthesis, and biological evaluation of a novel class of gamma-secretase modulators with PPARgamma activity.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Caproates; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Cricetulus; Cyclooxygenase Inhibitors; Drug Design; Humans; Peptide Fragments; PPAR gamma; Pyrimidines; Receptors, Notch; Sheep; Structure-Activity Relationship; Transcriptional Activation | 2010 |